Dare Bioscience News - DARE

Company Name	Stock Ticker Symbol	Market	Type
Dare Bioscience Inc	DARE	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	0.2827	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				0.2827

more quote information »

Recent News

Date	Time	Source	Heading
4/17/2024	8:00	IHNW	FeaturedGlucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring
4/11/2024	08:00	GLOBE	Daré Bioscience Announces Publication in Contraception of..
3/28/2024	08:00	GLOBE	Daré Bioscience Reports Full Year 2023 Financial Results and..
3/28/2024	07:42	IHMARKETNEWS	US Stock Futures Stable in Pre-Market On Path for..
3/21/2024	08:00	GLOBE	Daré Bioscience to Host Full Year 2023 Financial Results and..
2/22/2024	08:00	GLOBE	Daré Bioscience to Present at the International Society for..
1/31/2024	08:00	GLOBE	Daré Bioscience Announces Positive End-of-Phase 2 Meeting..
1/29/2024	16:18	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
1/26/2024	17:15	EDGAR2	Form 8-K - Current report
1/26/2024	16:30	GLOBE	Daré Bioscience Announces Executive Team and Board of..
1/19/2024	16:30	EDGAR2	Form 8-K - Current report
1/17/2024	08:00	GLOBE	Daré Bioscience Announces Grant to Support Biotherapeutic..
1/08/2024	08:00	EDGAR2	Form 8-K - Current report
1/04/2024	08:00	GLOBE	Daré Bioscience’s DARE-LARC1 Platform Technology Achieves..
12/26/2023	08:05	EDGAR2	Form 8-K - Current report
12/26/2023	08:00	GLOBE	Daré Bioscience Secures $12 million in Royalty-backed..
12/20/2023	08:05	EDGAR2	Form 8-K - Current report
12/20/2023	08:00	GLOBE	Daré Bioscience Announces Positive Topline Pharmacokinetic..
12/13/2023	08:00	GLOBE	Daré Bioscience Announces Funding Award Notice from the..
12/07/2023	08:00	GLOBE	Daré Bioscience Announces FDA Clearance of Investigational..
12/04/2023	08:00	GLOBE	Daré Bioscience Announces Commencement of Phase 3 Study of..
11/20/2023	08:00	GLOBE	Daré Bioscience and Premier Research Extend Strategic..
11/13/2023	08:00	GLOBE	Daré Bioscience to Present at the Sexual Medicine Society of..
11/09/2023	17:15	EDGAR2	Form 8-K - Current report
11/09/2023	16:02	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	08:05	EDGAR2	Form 8-K - Current report
11/09/2023	08:00	GLOBE	Daré Bioscience Reports Third Quarter 2023 Financial Results..
11/06/2023	08:00	GLOBE	Daré Bioscience to Participate in Three November Conferences
11/02/2023	08:00	GLOBE	Daré Bioscience to Host Third Quarter 2023 Financial Results..
11/01/2023	08:05	EDGAR2	Form 8-K - Current report
11/01/2023	08:00	GLOBE	Daré Bioscience Announces Additional Positive Data from..
10/16/2023	08:15	EDGAR2	Form 8-K - Current report
10/16/2023	08:00	GLOBE	Daré Bioscience Announces Achievement of First Commercial..
9/21/2023	08:00	GLOBE	Daré Bioscience Announces Grant Funding Installment to..
9/20/2023	08:00	GLOBE	Daré Bioscience to Present at The Menopause Society 2023..
9/11/2023	08:15	EDGAR2	Form 8-K - Current report
9/06/2023	08:00	GLOBE	Daré Bioscience to Participate in Upcoming Investor..
9/05/2023	08:00	GLOBE	Daré Bioscience Completes Previously Announced Equity..
8/30/2023	17:27	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
8/30/2023	16:05	EDGAR2	Form 8-K - Current report
8/30/2023	08:00	GLOBE	Daré Bioscience Announces $7.0 Million Registered Direct..
8/10/2023	16:01	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	08:05	EDGAR2	Form 8-K - Current report
8/10/2023	08:00	GLOBE	Daré Bioscience Reports Second Quarter 2023 Financial..
8/09/2023	08:00	GLOBE	Daré Bioscience Announces Publication in The Journal of The..
8/03/2023	08:00	GLOBE	Daré Bioscience to Host Second Quarter 2023 Financial..
7/31/2023	08:00	GLOBE	Daré Bioscience Announces Grant Award Supporting Development..
7/21/2023	16:01	EDGAR2	Form 8-K - Current report
7/11/2023	17:30	GLOBE	Daré Bioscience to Present at the 9th Annual International..
7/11/2023	08:00	GLOBE	Daré Bioscience Announces Additional Positive Data from..
7/06/2023	08:00	GLOBE	Daré Bioscience Announces Upcoming Webinar to Review..